Comment on: Association between the beta-blockers, calcium channel blockers, all-cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
作者信息
Zakiev Vadim, Gvozdeva Anna, Skotnikov Anton
机构信息
Russian Clinical and Research Center of Gerontology, Pirogov Russian National Research Medical University, Moscow, Russia.
Chazov National Medical Research Center of Cardiology, Myasnikov Institute of Clinical Cardiology, Moscow, Russia.
出版信息
Clin Cardiol. 2024 Jan;47(1):e24125. doi: 10.1002/clc.24125. Epub 2023 Sep 19.
Abstract
摘要
相似文献
1
Comment on: Association between the beta-blockers, calcium channel blockers, all-cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.评论：射血分数保留的心力衰竭患者中β受体阻滞剂、钙通道阻滞剂与全因死亡率及住院时长之间的关联：一项随机对照试验的荟萃分析
Clin Cardiol. 2024 Jan;47(1):e24125. doi: 10.1002/clc.24125. Epub 2023 Sep 19.
2
Association between the beta-blockers, calcium channel blockers, all-cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.β受体阻滞剂、钙通道阻滞剂与射血分数保留的心力衰竭患者全因死亡率及住院时间的相关性：一项随机对照试验的荟萃分析。
Clin Cardiol. 2023 Aug;46(8):845-852. doi: 10.1002/clc.24058. Epub 2023 Jun 4.
3
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
4
Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis.射血分数保留的心力衰竭患者使用β受体阻滞剂的荟萃分析。
Heart Fail Rev. 2015 Mar;20(2):193-201. doi: 10.1007/s10741-014-9453-8.
5
Are beta-blockers effective in heart failure with preserved ejection fraction?β受体阻滞剂对射血分数保留的心力衰竭是否有效？
Medwave. 2016 Nov 2;16(Suppl5):e6593. doi: 10.5867/medwave.2016.6593.
6
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂用于射血分数保留的慢性心力衰竭。
Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3.
7
Association of Nondihydropyridine Calcium Channel Blockers Versus β-Adrenergic Receptor Blockers With Risk of Heart Failure Hospitalization.非二氢吡啶类钙通道阻滞剂与β肾上腺素能受体阻滞剂与心力衰竭住院风险的关系。
Am J Cardiol. 2023 Jun 15;197:68-74. doi: 10.1016/j.amjcard.2023.04.013. Epub 2023 May 5.
8
Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis.β受体阻滞剂对射血分数保留的心力衰竭的影响：一项荟萃分析。
PLoS One. 2014 Mar 5;9(3):e90555. doi: 10.1371/journal.pone.0090555. eCollection 2014.
9
The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").射血分数保留的心力衰竭（“舒张性心力衰竭”）的治疗
Heart Fail Rev. 2006 Jun;11(2):141-6. doi: 10.1007/s10741-006-9488-6.
10
Pharmacotherapy of heart failure with normal ejection fraction (HFNEF)--a systematic review.射血分数正常心力衰竭的药物治疗（HFNEF）——系统评价。
Br J Clin Pharmacol. 2011 Sep;72(3):369-80. doi: 10.1111/j.1365-2125.2011.03998.x.
本文引用的文献
1
Association between the beta-blockers, calcium channel blockers, all-cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.β受体阻滞剂、钙通道阻滞剂与射血分数保留的心力衰竭患者全因死亡率及住院时间的相关性：一项随机对照试验的荟萃分析。
Clin Cardiol. 2023 Aug;46(8):845-852. doi: 10.1002/clc.24058. Epub 2023 Jun 4.
2
Correction.更正。
J Am Coll Cardiol. 2022 Mar 1;79(8):848. doi: 10.1016/j.jacc.2022.01.012.
3
Effect of β-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.β受体阻滞剂撤药对射血分数保留的心力衰竭患者功能能力的影响。
J Am Coll Cardiol. 2021 Nov 23;78(21):2042-2056. doi: 10.1016/j.jacc.2021.08.073.
4
Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).β受体阻滞剂在射血分数保留心力衰竭伴变时功能不全患者中的撤药：对心功能容量的影响 一项前瞻性、随机、对照试验（Preserve-HR 试验）的理论基础和研究设计。
Clin Cardiol. 2020 May;43(5):423-429. doi: 10.1002/clc.23345. Epub 2020 Feb 19.
5
Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.β受体阻滞剂的使用与射血分数保留的心力衰竭患者心力衰竭住院和心血管疾病死亡率的关系：TOPCAT 试验的二次分析。
JAMA Netw Open. 2019 Dec 2;2(12):e1916598. doi: 10.1001/jamanetworkopen.2019.16598.
6
The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies.β受体阻滞剂对射血分数保留的心力衰竭患者死亡率的影响：观察性队列研究和随机对照研究的荟萃分析
Int J Cardiol. 2017 Feb 1;228:4-10. doi: 10.1016/j.ijcard.2016.11.239. Epub 2016 Nov 11.
7
Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.老年射血分数保留的心力衰竭患者使用β受体阻滞剂：类别、剂量及预后
Int J Cardiol. 2014 May 15;173(3):393-401. doi: 10.1016/j.ijcard.2014.03.005. Epub 2014 Mar 11.
8
Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: a propensity-adjusted case-control populational study.新诊断的射血分数保留的心力衰竭患者使用β受体阻滞剂治疗的死亡率和发病率：一项倾向评分调整的病例对照人群研究。
Int J Cardiol. 2011 Jan 7;146(1):51-5. doi: 10.1016/j.ijcard.2009.06.009. Epub 2009 Jul 1.
9
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).奈必洛尔对老年左心室射血分数降低和保留的心力衰竭患者进行β受体阻滞：来自SENIORS（奈必洛尔干预对老年心力衰竭患者结局和再住院影响的研究）的数据
J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046.
Zotero 插件